ObjectiveNew information warrants updated recommendations for the 4 central issues in
antiretroviral therapy: when to start, what drugs to start with, when to change, and what to …

ContextSubstantial changes in the field of human immunodeficiency virus (HIV) treatment
have occurred in the last 2 years, prompting revision of the guidelines for antiretroviral …

ContextGuidelines for antiretroviral therapy are important for clinicians worldwide given the
complexity of the field and the varied clinical situations in which these agents are used. The …

Objective To update recommendations for antiretroviral therapy for adult human
immunodeficiency virus type 1 (HIV-1) infection, based on new information and drugs that …

Objective.—To provide recommendations for antiretroviral therapy based on information
available in mid-1998. Participants.—An international panel of physicians with expertise in …

Context Recent data regarding the consequences of untreated human immunodeficiency
virus (HIV) infection and the expansion of treatment choices for antiretroviral-naive and …

The availability of an increasing number of antiretroviral agents and the rapid evolution of
new information have introduced substantial complexity into treatment regimens for persons …

Context New trial data and drug regimens that have become available in the last 2 years
warrant an update to guidelines for antiretroviral therapy (ART) in human immunodeficiency …

Objective.—To provide current recommendations for antiretroviral therapy for human
immunodeficiency virus (HIV) disease. Participants.—The original International AIDS Society …

Importance New data and antiretroviral regimens expand treatment choices in resource-rich
settings and warrant an update of recommendations to treat adults infected with human …